Home > Physicians > McHutchison, John G.

John G. McHutchison, MD

John G. McHutchison, MD, Associate Director, Duke Clinical Research Institute, Director, GI/Hepatology Research

Associate Director, Duke Clinical Research Institute
Director, GI/Hepatology Research

Department / Division:
Medicine / Gastroenterology

Address:
DUMC 3850
Durham, NC 27710

Appointment Telephone:
919-684-2052

Office Telephone:
919-668-7193

Fax Telephone:
919-668-7164

Training:
  • MD, Melbourne University, Victoria (Australia), 1981

Residency:
  • Internal Medicine, Royal Melbourne Hospital, Victoria (Australia), 1982-1985

Fellowship:
  • Gastroenterology, Royal Melbourne Hospital, Victoria (Australia), 1986-1987
  • Hepatology, University Southern California, Los Angeles, 1988-1990

Clinical Interests:
Hepatitis B and C, ascites, noninvasive fibrosis markers, steatosis

Representative Publications:
White IR, Patel K, Symonds WT, Dev A, Griffin P, Tsokanas N, Skehel M, Liu C, Zekry A, Cutler P, Gattu M, Rockey DC, Berrey MM, McHutchison JG. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med. 2007 Jul 11;5(1):33. (2007) Abstract

Pockros PJ, Guyader D, Patton H, Tong MJ, Wright T, McHutchison JG, Meng TC. Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol. 2007 Aug;47(2):174-82. (2007) Abstract

Pawlotsky JM, Chevaliez S, McHutchison JG. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology. 2007 May;132(5):1979-98. (2007) Abstract

McHutchison JG, Manns MP, Brown RS Jr, Reddy KR, Shiffman ML, Wong JB. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.  Am J Gastroenterol.  2007 Apr;102(4):880-9. (2007) Abstract

Patel K, Norris S, Lebeck L, Feng A, Clare M, Pianko S, Portmann B, Blatt LM, Koziol J, Conrad A, McHutchison JG. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology. 2006 Feb;43(2):241-9. (2006) Abstract

Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ. 2006 Apr 29;332(7548):1013-7. (2006) Abstract

McHutchison JG, Patel K, Pockros P, Nyberg L, Pianko S, Yu RZ, Dorr FA, Kwoh TJ. A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. J Hepatol. 2006 Jan;44(1):88-96. (2006) Abstract

McHutchison JG, Bartenschlager R, Patel K, Pawlotsky JM. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice. J Hepatol. 2006 Feb;44(2):411-21. (2006) Abstract

Dienstag JL, McHutchison JG. American Gastroenterological Association medical position statement on the management of hepatitis C. Gastroenterology. 2006 Jan;130(1):225-30. (2006) Abstract

Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2006 Jun;4(6):797-801. (2006) Abstract

Bain VG, Yoshida EM, Kaita KD, Swain MG, Heathcote EJ, Garcia A, Moore PA, Yu R, McHutchison JG, Subramanian GM. Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa. Hepatol Res. 2006 Aug;35(4):256-62. (2006) Abstract

Bain VG, Kaita KD, Yoshida EM, Swain MG, Heathcote EJ, Neumann AU, Fiscella M, Yu R, Osborn BL, Cronin PW, Freimuth WW, McHutchison JG, Subramanian GM. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients. J Hepatol. 2006 Apr;44(4):671-8. (2006) Abstract

McHutchison JG, Shiffman ML, Cheung RC, Gordon SC, Wright TL, Pottage JC Jr, McNair L, Ette E, Moseley S, Alam J. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C. Antivir Ther. 2005;10(5):635-43. (2005) Abstract

McHutchison JG, Bacon BR. Chronic hepatitis C: an age wave of disease burden. Am J Manag Care. 2005 Oct;11(10 Suppl):S286-95; quiz S307-11. (2005) Abstract

Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology. 2005 Dec;42(6):1406-13. (2005) Abstract

Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation. 2005 Jul 15;80(1):145-8. (2005) Abstract

Bacon BR, McHutchison JG. Treatment issues with chronic hepatitis C: special populations and pharmacy strategies. Am J Manag Care. 2005 Oct;11(10 Suppl):S296-306; quiz S307-11. (2005) Abstract